Congress Eyes Generic Biotech Drugs
When Democrats take over Congress in January, they are likely to push for giving the Food and Drug Administration a process for approving generic biotechnology drugs, or follow-on protein products....To view the full article, register now.
Already a subscriber? Click here to view full article